Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹109 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹109 Cr
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹109 Cr
Positive
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,927.4 Cr -2.1% 1.9% -1.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹473,509.0 Cr 0.6% 6% 14.6% Stock Analytics
DIVIS LABORATORIES ₹196,881.0 Cr 1.2% 10.5% 7.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,832.0 Cr -0.4% 11% 40.8% Stock Analytics
CIPLA ₹113,894.0 Cr -1.6% -2.1% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,062.8 Cr -4.6% -14.8% -8.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.1%

1.9%

-1.3%

SENSEX

-1.1%

-0.2%

-6.6%


You may also like the below Video Courses